glp-1 とは 糖尿病治療薬のGLP-1受容体作動薬が炎症性筋疾患を改善 筋炎症と筋力の改善効果 GLP-1 Receptor Agonists – Peripheral
Description
While the recent phase 3 trial for orforglipron was specifically for type 2 diabetes and not weight loss, the study found that patients who took the drug lost considerable weight

Therefore, the following targets are recommended: 14 LDL-cholesterol less than 2.0 mmol/L (or less than 1.8 mmol/L if CV disease is established) HDL-cholesterol greater than 1.0 mmol/L triglycerides less than 2.0 mmol/L

Summary: There is a lot of conflicting advice around the use of GLP-1 medications before surgery, which can be overwhelming

Eur J Neurosci (2006) 24(10):273140.10.1111/j.1460-9568.2006.05157.x 107 JoY-HTalmageDARoleLW

BB: Project administration, Supervision, Writing original draft, Writing review & editing
